Fig. 2
From: Considerations for applying bioethics norms to a biopharmaceutical industry setting
Patient categories. There are two patient categories that must be considered when assessing bioethical responsibilities of the biopharmaceutical industry—current and future patients. Within the category of current patients, there are two subcategories—those for which there is not a clinical trial and those for which there is a clinical trial. Within the latter category, there are four additional subcategories. Most biopharmaceutical bioethics deliberations require consideration of at least two or more categories or subcategories